An open-label phase II study of E7070 in metastatic breast cancer patients previously treated with an anthracycline, a taxane, and capecitabine

Trial Profile

An open-label phase II study of E7070 in metastatic breast cancer patients previously treated with an anthracycline, a taxane, and capecitabine

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Sep 2009

At a glance

  • Drugs Indisulam (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Sponsors Eisai Medical Research
  • Most Recent Events

    • 18 Oct 2006 Status change
    • 18 Aug 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top